Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
about
Cargos and genes: insights into vesicular transport from inherited human diseaseNovel Insights and Therapeutics in Multiple SclerosisMultiple sclerosis-a quiet revolutionExpression of Ccl11 associates with immune response modulation and protection against neuroinflammation in ratsInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisMyelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosisEvolution of the blood-brain barrier in newly forming multiple sclerosis lesionsNonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?The neuropathological basis of clinical progression in multiple sclerosis.Expression of myoferlin in human airway epithelium and its role in cell adhesion and zonula occludens-1 expression.A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis.A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsyAngiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapiesImatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune responseSera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrierLysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells.Neurofascin as a novel target for autoantibody-mediated axonal injuryFibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.Pathoetiology of multiple sclerosis: are we barking up the wrong tree?Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.The relation between inflammation and neurodegeneration in multiple sclerosis brains.Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis.The molecular basis of neurodegeneration in multiple sclerosis.mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.Multiple sclerosis: Prospects and promise.Mechanisms of white matter damage in multiple sclerosis.Secondary Progressive Multiple Sclerosis: Definition and Measurement.Ibudilast for the treatment of multiple sclerosis.Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.Muscle membrane repair and inflammatory attack in dysferlinopathy.A novel method for subarachnoid hemorrhage to induce vasospasm in miceThe "window of susceptibility" for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines.Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 1.Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.Increased non-HDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
P2860
Q24648345-84FB0BC2-E365-44E0-91C1-038DFD4C6EBCQ26784619-06D57D96-A0BA-4DC5-881F-1485F97065E7Q26826930-CAE379AF-86CE-4699-BC2E-9B398070F0CBQ27300354-26B2ECA0-7184-49A6-8BFE-ECCEF07B1C19Q28080754-ECCEFDA6-77C8-4371-8E88-00F0F6076059Q28910423-7CB193FD-1AE0-4FBB-924E-A2726C832859Q30502812-3BA02236-A09E-46E8-938F-33760881B91CQ30871249-67507CD6-99EC-4529-971A-D138ED3068D1Q31139925-16D8DA38-D7BF-4BDA-8EF5-C75888947C80Q34156824-FDCB6429-63EF-465A-A35D-BFECF2D3D236Q34188436-8A45C228-3176-4685-8726-213551E57CC9Q34342055-C7B68199-82F9-4288-B996-D62EE5080EB6Q34374864-D13B23CD-517E-44D8-9ACD-6C066D1BD07AQ34464088-72E68AAF-1BFB-4CB4-9D1E-C8B1B6B6B1F3Q34499810-6019BAC7-9D67-4920-97A4-96CE539B15F1Q34512363-69E1C818-6502-411C-AE09-86E339B84BEEQ34599027-5EB6EA51-A372-4895-B04B-83536D2B3025Q35136280-389E4D53-8288-4485-9582-67AF64774389Q35883894-F27215AB-828D-4F4B-8F13-F6E5470E92DDQ36228999-A1EECD48-713C-4B9C-A7D7-29DBEEFC6289Q36445604-2A00265A-E7D1-4615-B8E0-794098E9499DQ36659375-9C85DEA5-93CD-4BAF-8667-2F3A5EA32725Q36904407-A8E00E16-1140-448E-95AF-2DBB26C353B5Q37163249-16A33B5C-3E5C-42D1-A3E3-7696B0F74D39Q37181308-3237E7C5-71FB-4588-977E-37EDAAB5F5CCQ37849615-24213B0C-488F-41C3-ABD4-BF6AC76DC3F7Q37893199-8C949FC6-9B7E-4310-A3B5-9C22EEE2DE8BQ37920009-EF3B4B80-A32A-4762-A9B9-9583A43A1CEEQ38050335-3F0EF940-DA01-4A1D-92F4-ABF4B5D3AB73Q38129775-4B084DA4-C26A-4E07-8027-E193C2B7F337Q38182524-87E892D3-776E-48FD-BFF5-65347301E72DQ38831720-2EFDDEB8-EFD5-4E87-B4AD-ECC649CE1022Q38921778-0EDAF54B-601F-4CD0-A8D1-B512DFD1A627Q39091396-4AE524A7-F00B-4BEE-B3D3-AE003215E670Q42209023-D8E73FBA-6EDE-4E72-9E71-B324F8D456B1Q42221488-DCA51EA2-1ECE-4F0E-8828-5069D1D70530Q43103712-AD505DA1-A393-4AF9-849A-27158AB62FC4Q44985002-2E5D79C2-1F08-49CF-9626-FB9996E891D4Q46028716-6559A80E-6757-4D3F-9AF1-5B781365ABD1Q47413106-44D97600-B27F-4B34-9EC1-FA0767850B64
P2860
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
@en
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
@nl
type
label
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
@en
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
@nl
prefLabel
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
@en
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
@nl
P2093
P2860
P50
P1476
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis
@en
P2093
Alexandra Kutzelnigg
Grace Gordon
Reginald E Bittner
Roland Grundtner
Sonja Hochmeister
Thomas Korosec
P2860
P304
P356
10.1097/01.JNEN.0000235119.52311.16
P577
2006-09-01T00:00:00Z